• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
AXGN

AXGN

AxoGen, Inc.

NASDAQHealthcareMedical - DevicesUS

USD40.63

+1.17 (+2.97%)

Rating:C-

Company Profile

CEO

Michael D. Dale

IPO Date

1986-12-17

Sector

Healthcare

Industry

Medical - Devices

Exchange

NASDAQ

Country

US

Market Metrics

Open

$39.50

Prev. Close

$39.46

Day Low

$39.25

Day High

$40.77

52W Low

$9.22

52W High

$45.83

Market Cap

$2.16B

Volume

0.53M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

26.2%

Avg Negative

2.9%

Avg Neutral

70.9%

News Feed

Axogen: Renewed Covid-19 Worries Hitting, But The Growth Story Is Very Appealing

Seeking Alpha·8/25/2021·↑ positive

AxoGen's (AXGN) CEO Karen Zaderej on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/5/2021·↓ negative

AxoGen (AXGN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks Investment Research·7/28/2021·↑ positive

Axogen, Inc. Appoints John H. Johnson to Board of Directors

GlobeNewsWire·7/19/2021·↑ positive

Axogen, Inc. to Report Second Quarter Financial Results and Host Conference Call on August 4, 2021

GlobeNewsWire·7/14/2021·↑ positive

Axogen, Inc. to present at the Jefferies Virtual Healthcare Conference and the JMP Securities Life Sciences Conference

GlobeNewsWire·5/18/2021·↑ positive

AxoGen, Inc. (AXGN) CEO Karen Zaderej on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/9/2021·↓ negative

AxoGen (AXGN) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research·5/5/2021·↑ positive

Recap: Axogen Q1 Earnings

Benzinga·5/5/2021·↑ positive

Axogen, Inc. Promotes Peter J. Mariani to Executive Vice President and Chief Financial Officer

GlobeNewsWire·3/1/2021·↑ positive